Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

Q4 2024 Management View Kevin Sayer, CEO, highlighted that Q4 2024 organic revenue growth was 8%, contributing to a full-year organic growth of 12%, aligned with guidance. The company ended 2024 with ...

Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

Dexcom (Nadsaq:DXCM) shares fell after hours today on fourth-quarter results that came in mixed compared to the consensus forecast.

We have excluded third-party attorney’s fees, costs, and expenses incurred by Dexcom exclusively in connection with Dexcom’s patent infringement litigation against Abbott Diabetes Care, Inc., as ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

The Biosensors Market is growing with demand for rapid, accurate diagnostics in healthcare, food safety, and environmental monitoring, driven by advances in biotechnology.Austin, Feb. 12, 2025 (GLOBE ...

Global Biohacking Market Set for Exponential Growth, Driven by Wearable Technology and Advanced DiagnosticsPune, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Global Biohacking Market Size & Growth Analysis: ...

The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...

G6 continuous glucose monitor (CGM) receivers deliver glucose readings and alerts. However, certain devices may experience an ...

Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...

Wearables have become catalysts for a proactive approach to healthcare, predicting what is about to happen based on current ...